Saudi Arabia’s King Faisal Specialist Hospital and Research Centre pioneers non-invasive prostate cancer treatment

SAUDI ARABIA—King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has achieved a significant medical breakthrough by performing the Kingdom’s first high-intensity focused ultrasound (HIFU) treatment for prostate cancer.

This innovative approach represents a major advancement in how physicians treat early-stage prostate tumors, offering patients a non-invasive alternative to traditional surgical methods.

The HIFU technique works by directing powerful ultrasound waves precisely at cancerous tissue within the prostate gland.

This targeted approach destroys tumor cells while leaving the surrounding healthy tissue intact, a crucial advantage that minimizes potential side effects and complications.

Unlike conventional surgery, the procedure requires no incisions and leaves no visible scars on the patient’s body.

Advanced technology drives precision

The hospital’s medical team performs the entire treatment in a single session using a sophisticated fusion-guided system.

This system merges magnetic resonance imaging (MRI) with specialized prostate-targeting technology, creating a detailed map that helps physicians identify the exact location of cancerous tissue.

The integration of these imaging technologies ensures that doctors can visualize the treatment area with exceptional clarity before delivering therapy.

A state-of-the-art robotic platform further enhances the procedure’s accuracy.

The robot positions the ultrasound probe with millimeter-level precision, then delivers focused energy directly to the targeted tissue.

This automated system eliminates human variability in probe placement, ensuring consistent and safe treatment delivery for every patient.

Patient selection and clinical outcomes

KFSH currently offers this treatment to patients diagnosed with low- to intermediate-risk prostate cancer in its early stages.

These patients typically have tumors that remain confined to the prostate gland and have not spread to surrounding organs or tissues.

The hospital’s early clinical results show promising outcomes, with patients experiencing stable disease control following treatment.

Compared to standard surgical and radiation therapies, the HIFU procedure significantly reduces the time patients spend in the hospital.

Many patients return home the same day or within 24 hours of treatment.

The minimally invasive nature of the procedure also translates to fewer complications, allowing patients to resume their normal activities more quickly than those who undergo traditional surgery.

Artificial intelligence on the horizon

The hospital anticipates that artificial intelligence will play an increasingly important role in refining this treatment approach.

AI algorithms could analyze imaging data more rapidly and accurately, potentially identifying cancerous tissue that human observers might miss.

This technology may also help physicians predict which patients will benefit most from HIFU treatment, expanding the range of cases suitable for this therapy.

Comprehensive cancer care program

The HIFU treatment forms just one component of KFSH’s comprehensive prostate cancer program.

The Center of Excellence for Surgery provides patients with access to multiple treatment modalities, including robotic-assisted surgery for cases requiring surgical intervention.

The program also offers radiation therapy options, focal therapies that target specific areas, and systemic treatments for cancer that has spread beyond the prostate.

A multidisciplinary team of specialists collaborates to manage each patient’s care, whether they present with localized disease, locally advanced cancer, or metastatic spread.

The center’s high case volume allows its medical staff to maintain extensive experience across all types of prostate cancer presentations.

International recognition

These medical advances contribute to KFSH’s growing international reputation.

The hospital ranks first in the Middle East and North Africa region and holds the 12th position globally among the world’s top 250 Academic Medical Centers for 2026.

Brand Finance 2025 has recognized it as the most valuable healthcare brand in both the Kingdom and the broader Middle East region.

Newsweek has included the hospital in multiple prestigious lists, including the World’s Best Hospitals 2025, the World’s Best Smart Hospitals 2026, and the World’s Best Specialized Hospitals 2026.